Reed’s launches Culture Club Kombucha
LOS ANGELES — Reed’s has expanded its portfolio to include an organic kombucha beverage.
Reed’s Culture Club Kombucha will be introduced in four, ginger-based formulas: Goji ginger, cranberry ginger, lemon raspberry ginger and hibiscus grapefruit ginger.
"Over the last year we have engaged some of the best kombucha brewing experts within the industry today to help us co-develop what we consider to be the best, raw organic kombucha on the market," Reed’s founder and CEO Chris Reed said. "Each flavor extension is enhanced with our trademark fresh ginger root, the finest organic specialty teas, fresh pressed juices, spices, all brewed in spring water. We really out did ourselves with the creation of the new packaging and design, which should generate significant product trial."
Sabona launches magnetic athletic necklace
SIKESTON, Mo. — Sabona has introduced a magnetic athletic necklace to its product line.
The necklaces feature 1,200 gauss magnets embedded in a black accent and are combined with minus ion producing materials in a colorful stretch fabric.
"We introduced our first leather magnetic necklace at the beginning of 2012 and are pleased to introduce a sporty, casual necklace to the Sabona line," Sabona national sales manager Corey McNew said.
The necklaces, which are available in black, red, white, blue and pink and retail for a suggested retail price of $24.99.
Bill offers hope for patients with rare diseases
WASHINGTON — A bill passed in the Senate will provide measures to speed up the development of treatments for people who desperately need them.
The Senate voted Tuesday to pass S. 3187, the Food and Drug Administration Safety and Innovation Act, which now awaits President Barack Obama’s signature. The House approved a similar bill last week.
Among other features, the bill enhances accelerated patient access to new medical treatments; encourages the development of medical devices for small patient populations; provides for accelerated development of therapies that show early promise; enhances consultation with medical experts on rare diseases; and creates a priority review voucher incentive system for rare children’s diseases.
The legislation won praise from a group focused on rare diseases.
"Only about 250 of the nearly 7,000 diseases considered rare in the United States have therapies," National Organization for Rare Disorders president and CEO Peter Saltonstall said. "But treatments are desperately needed because most rare diseases are serious, many are life-threatening and about two-thirds of the patients are children."